Medicare Enrolled
Dr. Douglas Roegner, M.D.
Urology Physician · Rockford, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Roegner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roegner?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Roegner
Dr. Douglas Roegner is an urology physician in Rockford, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Roegner performed 3,520 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Roegner received a total of $7,000 from 53 pharmaceutical and/or device companies across 367 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Roegner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 27% volume in IL
$7,000 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,520
Medicare services
Top 27% in IL for urology physician
Not available
Unique patients (not deduplicated)
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 700 | $2 | $7 |
| Leuprolide injectable, camcevi, 1 mg | 588 | $67 | $200 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
521 | $2 | $31 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
291 | $86 | $250 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
250 | $7 | $192 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
183 | $8 | $28 |
| PSA test (prostate cancer screening) | 181 | $18 | $100 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
128 | $44 | $246 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
115 | $66 | $175 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 102 | $140 | $1,025 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
82 | $119 | $375 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
67 | $164 | $590 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
45 | $69 | $130 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
40 | $16 | $83 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $24 | $130 |
| Simple change of bladder tube | 31 | $70 | $225 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
28 | $82 | $300 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
26 | $82 | $280 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
20 | $104 | $478 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
19 | $188 | $561 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
19 | $45 | $490 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $94 | $399 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
17 | $99 | $160 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
14 | $63 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,000
Total received (2018-2024)
Avg $1,000/year across 7 years
Top 25% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
367
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$888
2023
$1,636
2022
$1,012
2021
$622
2020
$362
2019
$1,436
2018
$1,044
Payments by company (2024)
Sumitomo Pharma America, Inc.
$166
Janssen Biotech, Inc.
$111
Merck Sharp & Dohme LLC
$67
Tolmar, Inc.
$62
Astellas Pharma US Inc
$62
Endo USA, Inc.
$53
Tempus AI, Inc
$50
Teleflex LLC
$41
Bayer Healthcare Pharmaceuticals Inc.
$40
Boston Scientific Corporation
$35
ABBVIE INC.
$35
AstraZeneca Pharmaceuticals LP
$34
Verity Pharmaceuticals Inc.
$34
Endo Pharmaceuticals Inc.
$33
Dendreon Pharmaceuticals LLC
$30
ACCORD HEALTHCARE, INC.
$18
Myriad Genetic Laboratories, Inc.
$16
Top 3 companies account for 38.7% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,054
Janssen Biotech, Inc.
$807
Dendreon Pharmaceuticals LLC
$591
Sumitomo Pharma America, Inc.
$583
Ferring Pharmaceuticals Inc.
$292
PFIZER INC.
$250
Endo Pharmaceuticals Inc.
$239
Bayer HealthCare Pharmaceuticals Inc.
$225
AstraZeneca Pharmaceuticals LP
$220
Myovant Sciences Inc.
$174
AbbVie, Inc.
$165
Organogenesis Inc.
$164
Verity Pharmaceuticals Inc.
$162
Merck Sharp & Dohme LLC
$162
Boston Scientific Corporation
$128
ABBVIE INC.
$116
SANOFI-AVENTIS U.S. LLC
$100
Progenics Pharmaceuticals, Inc.
$98
Retrophin, Inc.
$97
TOLMAR Pharmaceuticals, Inc.
$87
Teleflex LLC
$76
AbbVie Inc.
$73
Coloplast Corp
$73
Olympus America Inc.
$64
Amgen Inc.
$64
Travere Therapeutics, Inc.
$63
Tolmar, Inc.
$62
Rochester Medical Corporation
$61
Allergan Inc.
$59
Antares Pharma, Inc.
$59
Endo USA, Inc.
$53
Tempus AI, Inc
$50
AngioDynamics, Inc.
$49
Cook Medical LLC
$46
COLOPLAST CORP
$43
Bayer Healthcare Pharmaceuticals Inc.
$40
PROCEPT BioRobotics Corporation
$37
GENZYME CORPORATION
$34
Blue Earth Diagnostics Limited
$32
Bard Access Systems, Inc.
$31
BOSTON SCIENTIFIC CORPORATION
$24
180 Medical, Inc.
$22
UROVANT SCIENCES INC
$22
ACCORD HEALTHCARE, INC.
$18
UROGEN PHARMA, INC.
$18
Accord Healthcare, Inc.
$17
Myriad Genetic Laboratories, Inc.
$16
Merck Sharp & Dohme Corporation
$15
UroGen Pharma, Inc.
$14
Sun Pharmaceutical Industries Inc.
$14
DENTSPLY IH Inc.
$13
NeoTract Inc.
$12
ConvaTec Inc.
$11
Top 3 companies account for 35.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS 800 Artificial Urinary Sphincter · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Apligraf · Axumin · BOTOX · CAMCEVI · Cook Medical Biopsy · Dornier Medilas H Solvo · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GREENLIGHT · GentleCath · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Nubeqa · ORGOVYX · OTREXUP · PROGEL · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolia · Puraply · RESONANCE · REZUM · ROADRUNNER · SPEEDICATH · SenSura Mio · SpeediCath · TOVIAZ · Trelstar · UROLIFT · UroLift · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
17
County median income
$64,363
Nearest hospital to ZIP centroid (approximate)
SAINT ANTHONY MEDICAL CENTER
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Roegner is a clinical cardiology specialist, with above-average Medicare volume (top 27% in IL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Roegner experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Roegner performed 700 bcg treatment for bladder cancer services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Roegner receive payments from pharmaceutical companies?
Yes. Dr. Roegner received a total of $7,000 from 53 companies across 367 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Roegner's costs compare to other urology physicians in Rockford?
Dr. Roegner's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Roegner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Rockford
Browse urology physicians in Rockford ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology